Clinical Trials on Raynaud's Disease Secondary to Scleroderma in United Kingdom
Total 1649 results
-
MediQuest TherapeuticsUnknownRaynaud's Disease | Raynaud's Disease Secondary to Scleroderma | Raynaud's Disease Secondary to Other Autoimmune DiseaseUnited States
-
MediQuest TherapeuticsCompletedRaynaud's Disease | Raynaud's Disease Secondary to Scleroderma | Raynaud's Disease Secondary to Autoimmune DiseaseUnited States
-
ActelionCompletedRaynaud's Phenomenon Secondary to Systemic SclerosisGermany, France, United Kingdom
-
MediQuest TherapeuticsCompletedRaynaud Disease | Raynaud Disease Secondary to Scleroderma | Raynaud Secondary to Other Autoimmune DiseaseUnited States
-
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences...CompletedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited States
-
Eicos Sciences, Inc.CompletedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited States
-
PfizerArena is a wholly owned subsidiary of PfizerTerminatedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited Kingdom, United States
-
Eicos Sciences, Inc.CompletedRaynaud Phenomenon Secondary to Systemic SclerosisUnited States
-
Johns Hopkins UniversityCompletedScleroderma | RaynaudUnited States
-
Covis Pharma S.à.r.l.CompletedRaynaud's Phenomenon Secondary to Connective Tissue DiseaseUnited States
-
Vicore Pharma ABSGS Life Sciences, a division of SGS Belgium NVCompleted
-
University of ManchesterNorthern Care Alliance NHS Foundation Trust; Royal Free Hospital NHS Foundation... and other collaboratorsEnrolling by invitationSystemic Sclerosis | Raynaud PhenomenonUnited Kingdom
-
Cytori TherapeuticsCompletedSystemic Sclerosis | Scleroderma | Raynaud Phenomena | Raynaud's DiseaseUnited States
-
Sheffield Hallam UniversitySheffield Teaching Hospitals NHS Foundation TrustCompletedQuality of Life | Systemic Sclerosis | Raynaud's PhenomenonUnited Kingdom
-
University of NottinghamCompleted
-
MediQuest TherapeuticsCompletedAutoimmune Diseases | Scleroderma | Raynaud's DiseaseUnited States, United Kingdom, Sweden
-
Gesynta Pharma ABErgomedCompletedSystemic SclerosisUnited Kingdom, Poland, Belgium, Netherlands
-
Johns Hopkins UniversityAllerganCompletedScleroderma | Raynaud's SyndromeUnited States
-
University of PortsmouthUniversity of Exeter; Loughborough UniversityCompletedRaynaud PhenomenonUnited Kingdom
-
University of PittsburghApollo NeuroscienceCompletedFatigue | Systemic Sclerosis | Raynaud PhenomenonUnited States
-
University of Toledo Health Science CampusElectroCore INCTerminatedRaynaud Disease | Raynaud Phenomenon | Primary Raynaud Phenomenon | Raynaud SyndromeUnited States
-
University of MichiganCompleted
-
University of Central FloridaTerminatedRaynaud PhenomenonUnited States
-
University of MinnesotaWithdrawnRaynaud Disease | Raynaud Phenomenon | Raynaud SyndromeUnited States
-
MediQuest TherapeuticsCompletedRaynaud's PhenomenonUnited States
-
Northwestern UniversityEli Lilly and CompanyCompleted
-
Orion Corporation, Orion PharmaTerminatedRaynaud's PhenomenonUnited Kingdom
-
Procris PharmaceuticalsCompletedRaynaud's PhenomenonUnited States
-
Brigham and Women's HospitalUnited TherapeuticsCompletedRaynaud's PhenomenonUnited States
-
Southern Illinois UniversityCompleted
-
Primus PharmaceuticalsCompletedRaynaud's DiseaseUnited States
-
MediQuest TherapeuticsUnknownRaynaud DiseaseUnited States
-
Otsuka America PharmaceuticalCompletedRaynaud's DiseaseUnited States
-
Emory UniversityCompleted
-
Jose Soberon, MDTerminatedScleroderma, Diffuse | Peripheral Vascular Disease | Raynaud Disease | CREST SyndromeUnited States
-
Emory UniversityAmerican Society for Surgery of the HandRecruiting
-
University College, LondonMedical Research CouncilCompletedChronic Kidney Disease | Scleroderma | Scleroderma Renal CrisisUnited Kingdom
-
University of ManchesterCompletedUlcer | Scleroderma, SystemicUnited Kingdom
-
Otsuka America PharmaceuticalCompletedRaynaud's DiseaseUnited States
-
GlaxoSmithKlineCompletedScleroderma, SystemicUnited Kingdom
-
University of the West of ScotlandSwansea UniversityCompletedTo Assess the Impact of the HIT Intervention on Physiological Responses | To Assess the Role of a Secondary High School as a Setting for Promoting Healthy Eating and PA Behaviours | To Determine the Associations Between CVD Risk Factors at Baseline in 15 - 18 Year Old YouthUnited Kingdom
-
MediQuest TherapeuticsCompletedRaynaud's DiseaseUnited States
-
Mead Johnson NutritionWithdrawnCow's Milk Allergy | Intolerance to Extensively Hydrolyzed Formulas | Intolerance to Breast MilkUnited Kingdom
-
University of EdinburghNHS LothianCompletedPain | Toxicity Due to Radiotherapy | Cancer Induced Bone Pain | Secondary Malignant Neoplasm of BoneUnited Kingdom
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)CompletedBreast Cancer | Long-term Effects Secondary to Cancer Therapy in Adults | Skin Reactions Secondary to Radiation TherapyUnited States
-
MediQuest TherapeuticsCompletedRaynaud's DiseaseUnited States, Canada
-
University College, LondonCSL BehringUnknown
-
University College, LondonVersus ArthritisActive, not recruitingSystemic Sclerosis | Limited Cutaneous Systemic SclerosisUnited Kingdom
-
Sheffield Hallam UniversityKarolinska Institutet; Leiden University; Rikshospitalet University Hospital; Aristotle... and other collaboratorsRecruiting
-
Royal Brompton & Harefield NHS Foundation TrustUniversity College London Hospitals; Imperial College London; University of East...CompletedInterstitial Lung Disease | Scleroderma | Idiopathic Inflammatory Myositis | Mixed Connective Tissue DiseaseUnited Kingdom